Federal Supply Schedule V797P2009D

Golden State Medical Supply, Inc. (UEI: GQLDJJ8AQNN5) was awarded a single-award Indefinite Delivery Contract by the Medical Supply Chain, a defense-focused federal agency, on January 26, 2022, with a ceiling value of $24.4 million and an ultimate completion date of January 25, 2027. This contract represents a standard five-year Indefinite Delivery Vehicle structure typical of federal pharmaceutical procurement programs. The contract carries no set-aside designation, indicating the award was...

Golden State Medical Supply, Inc. was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on June 23, 2024, to supply Carbamazepine 200 milligram tablets to multiple federal healthcare systems. The contract carries a ceiling value of approximately $4.05 million and operates on a base year from June 23, 2024, through June 22, 2025, with four one-year option periods extending through June 22, 2026. No set-aside provisions were...

GlaxoSmithKline, LLC has been awarded a multiple-award Indefinite Delivery Contract by the Centers for Disease Control and Prevention (CDC) to supply pediatric vaccines for the Vaccines for Children (VFC) program. The contract, valued at $1.49 billion, covers the period from April 1, 2025, through March 31, 2026, with no set-aside designation applied. Under this solicitation, GlaxoSmithKline will manufacture and deliver standard commercial pediatric vaccines to support immunization efforts for...

Golden State Medical Supply, Inc. was awarded a single-award Indefinite Delivery Contract by the VA National Acquisition Center for the supply of Rosuvastatin Calcium Tablets, a widely-prescribed statin medication used for cholesterol management. The contract, valued at $27.78 million, commenced on February 11, 2024, with a base ordering period extending through February 10, 2025, followed by four one-year renewal options through February 10, 2027. The pharmaceutical supply will be distributed...

Sanofi-Aventis U.S. LLC has been awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center with a ceiling value of $465.4 million. The contract, effective July 1, 2025 through June 30, 2026, with four one-year option periods, procures human insulin products for distribution across multiple federal healthcare agencies including the Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health...

The Defense Health Agency awarded a single-award Blanket Purchase Agreement to Cardinal Health 414, LLC, with a ceiling value of $7.5 million and a performance period extending through September 14, 2030. This indefinite delivery vehicle procures radiopharmaceutical supplies for use across the federal healthcare system, including military treatment facilities and other Defense Health Agency medical centers. Cardinal Health 414, operating from its primary facility in Dublin, Ohio, provides a...

Prasco, LLC, a pharmaceutical manufacturer and distributor headquartered in Mason, Ohio, was awarded a single-award Indefinite Delivery Contract (IDC) by the Medical Supply Chain on June 5, 2024, with a ceiling value of $31.7 million and a performance period extending through June 4, 2034. The contract establishes a framework for the Medical Supply Chain, a defense-focused federal agency, to procure pharmaceutical and medical supply products on an indefinite quantity basis. Under this IDV...

Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., was awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 9 (VISN 9) on October 1, 2024, with a ceiling value of $2.22 million and a performance period extending through September 30, 2029. The contract procures radiopharmaceuticals and medical isotopes for the Louisville Veterans Affairs Medical Center on an as-needed basis to support nuclear medicine, diagnostic imaging, and therapeutic...

Cepheid, Inc. has been awarded a single-award Indefinite Delivery Contract (IDC) by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) with a ceiling value of $3.4 million and an ultimate completion date of March 31, 2026. The contract, awarded April 1, 2024, procures Cepheid molecular diagnostic testing kits designed for use with Cepheid GeneXpert analyzers currently deployed at VA Southern Nevada Healthcare System facilities in Las Vegas, Nevada. The test kits...

The federal contract IDV award is for the procurement of influenza virus vaccines for the 2024-2025 flu season. The prime contractor is Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. This award is being made by the U.S. Department of Veterans Affairs (VA) National Acquisition Center and will be used to supply vaccines to the VA, State Veteran Homes, Bureau of Prisons, Indian Health Service, and Captain James A. Lovell Federal Health Care Center. The...